DK1392670T3 - Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater - Google Patents
Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivaterInfo
- Publication number
- DK1392670T3 DK1392670T3 DK02743057T DK02743057T DK1392670T3 DK 1392670 T3 DK1392670 T3 DK 1392670T3 DK 02743057 T DK02743057 T DK 02743057T DK 02743057 T DK02743057 T DK 02743057T DK 1392670 T3 DK1392670 T3 DK 1392670T3
- Authority
- DK
- Denmark
- Prior art keywords
- methylamine
- thiophen
- furan
- substituted
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10125145A DE10125145A1 (de) | 2001-05-22 | 2001-05-22 | Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate |
PCT/EP2002/005542 WO2002094802A1 (de) | 2001-05-22 | 2002-05-21 | Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1392670T3 true DK1392670T3 (da) | 2005-08-08 |
Family
ID=7685874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02743057T DK1392670T3 (da) | 2001-05-22 | 2002-05-21 | Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater |
Country Status (17)
Country | Link |
---|---|
US (2) | US6878740B2 (es) |
EP (1) | EP1392670B1 (es) |
JP (1) | JP2004532246A (es) |
AR (1) | AR035982A1 (es) |
AT (1) | ATE299873T1 (es) |
AU (1) | AU2002338989B2 (es) |
CA (1) | CA2448038C (es) |
DE (2) | DE10125145A1 (es) |
DK (1) | DK1392670T3 (es) |
ES (1) | ES2242869T3 (es) |
HU (1) | HUP0401162A3 (es) |
MX (1) | MXPA03010601A (es) |
PE (1) | PE20021099A1 (es) |
PL (1) | PL367535A1 (es) |
PT (1) | PT1392670E (es) |
SI (1) | SI1392670T1 (es) |
WO (1) | WO2002094802A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
KR100553398B1 (ko) | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | 티에노[3,2-c]피리딘 유도체의 제조 방법 및 이에사용되는 중간체 |
ES2421723T3 (es) | 2009-07-08 | 2013-09-05 | Dermira Canada Inc | Análogos de TOFA útiles en el tratamiento de trastornos o afecciones dermatológicas |
CN105263473A (zh) * | 2013-11-22 | 2016-01-20 | 梯瓦优质制药产品研发股份有限公司 | 可吸入药物 |
CN109153659A (zh) * | 2016-05-31 | 2019-01-04 | 翰林大学产学研合作团队 | 五元杂环衍生物、其制备方法及包含其的药剂学组合物 |
CN112521357B (zh) * | 2020-08-31 | 2021-10-08 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性hnk衍生物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3816457A (en) * | 1973-01-05 | 1974-06-11 | Richardson Merrell Inc | Lactamimide derivatives |
US3890445A (en) * | 1973-01-05 | 1975-06-17 | Richardson Merrell Inc | Lactamimide derivatives useful as hypoglycemic agents |
WO2001068816A1 (en) | 2000-03-13 | 2001-09-20 | Smithkline Beecham Corporation | Human histamine h3 gene variant-3 |
DE10012820A1 (de) * | 2000-03-16 | 2001-09-20 | Bayer Ag | Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine |
DE10059864A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
-
2001
- 2001-05-22 DE DE10125145A patent/DE10125145A1/de not_active Withdrawn
-
2002
- 2002-05-17 AR ARP020101843A patent/AR035982A1/es not_active Application Discontinuation
- 2002-05-21 PE PE2002000428A patent/PE20021099A1/es not_active Application Discontinuation
- 2002-05-21 JP JP2002591475A patent/JP2004532246A/ja active Pending
- 2002-05-21 HU HU0401162A patent/HUP0401162A3/hu unknown
- 2002-05-21 DK DK02743057T patent/DK1392670T3/da active
- 2002-05-21 MX MXPA03010601A patent/MXPA03010601A/es active IP Right Grant
- 2002-05-21 SI SI200230178T patent/SI1392670T1/sl unknown
- 2002-05-21 CA CA2448038A patent/CA2448038C/en not_active Expired - Fee Related
- 2002-05-21 EP EP02743057A patent/EP1392670B1/de not_active Expired - Lifetime
- 2002-05-21 ES ES02743057T patent/ES2242869T3/es not_active Expired - Lifetime
- 2002-05-21 DE DE50203686T patent/DE50203686D1/de not_active Expired - Lifetime
- 2002-05-21 PT PT02743057T patent/PT1392670E/pt unknown
- 2002-05-21 WO PCT/EP2002/005542 patent/WO2002094802A1/de active IP Right Grant
- 2002-05-21 PL PL02367535A patent/PL367535A1/xx not_active Application Discontinuation
- 2002-05-21 AU AU2002338989A patent/AU2002338989B2/en not_active Ceased
- 2002-05-21 AT AT02743057T patent/ATE299873T1/de not_active IP Right Cessation
-
2003
- 2003-11-21 US US10/717,932 patent/US6878740B2/en not_active Expired - Fee Related
-
2005
- 2005-03-07 US US11/072,962 patent/US7317034B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE50203686D1 (en) | 2005-08-25 |
CA2448038A1 (en) | 2002-11-28 |
PT1392670E (pt) | 2005-10-31 |
DE10125145A1 (de) | 2002-11-28 |
PL367535A1 (en) | 2005-02-21 |
EP1392670A1 (de) | 2004-03-03 |
MXPA03010601A (es) | 2004-03-09 |
EP1392670B1 (de) | 2005-07-20 |
ATE299873T1 (de) | 2005-08-15 |
US7317034B2 (en) | 2008-01-08 |
AR035982A1 (es) | 2004-07-28 |
HUP0401162A3 (en) | 2007-05-02 |
ES2242869T3 (es) | 2005-11-16 |
HUP0401162A2 (hu) | 2004-10-28 |
SI1392670T1 (sl) | 2005-12-31 |
WO2002094802A1 (de) | 2002-11-28 |
US20050148550A1 (en) | 2005-07-07 |
US6878740B2 (en) | 2005-04-12 |
US20040152734A1 (en) | 2004-08-05 |
PE20021099A1 (es) | 2003-01-25 |
JP2004532246A (ja) | 2004-10-21 |
CA2448038C (en) | 2010-09-28 |
AU2002338989B2 (en) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE319451T1 (de) | Tetrahydrochinolin-derivate | |
ATE312827T1 (de) | 3-substituierte-4-pyrimidonderivate | |
DK1292604T3 (da) | 2-Aminocarbonyl-9H-purinderivater | |
NO20041975L (no) | Bicyklisk oksopyridin og oksopyrimidinderivater | |
PT1411764E (pt) | Cerca | |
ATE288437T1 (de) | Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e | |
ATE298332T1 (de) | Decahydro-isochinolinderivate | |
DK1280809T3 (da) | Antitumorecteinascidinderivater | |
NO20014597D0 (no) | Fremgangsmåte | |
EE200300447A (et) | Asendatud bensofuraan-2-karboksamiidide derivaadid | |
DE60223031D1 (de) | Arylpiperazin gebundene tetrahydroindolonderivate | |
DE60135230D1 (de) | Aminocyclohexan-derivate | |
DK1322593T3 (da) | O-substituerede-6-methyl-tramadol-derivater | |
DK1246791T3 (da) | Aminomethyl-phenyl-cyklohexanonderivater | |
ATE299873T1 (de) | Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate | |
DE60117096D1 (de) | Dihydroindol- und tetrahydrochinolinderivate | |
ATE382601T1 (de) | Substituierte 4-aminocyclohexanolderivate | |
ATA18372001A (de) | Gelenksbolzenbaueinheit | |
DE60202381D1 (de) | Paroxetin-n-formyl-derivate | |
ATA13992002A (de) | Schlackengranulierungsanlage | |
DE60219418T8 (de) | Silanylphenole und -naphthole | |
ATE354561T1 (de) | Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen | |
ATE374776T1 (de) | Pyrrolotriazolopyrimidinonderivate | |
NO20024393D0 (no) | 2-fenylpyran-4-on-derivater | |
AT500276B8 (de) | Radschwenksystem |